Perifosine

Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma

Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas

Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma

Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas

Perifosine in Treating Patients With Advanced Solid Tumors

Study of Perifosine + Capecitabine for Colon Cancer Patients

Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma

A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's Macroglobulinemia

Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia

A Food Effect and QTc Study of Perifosine in Patients With Advanced Malignancies

Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients

Trial of Two Schedules of Perifosine for Patients With Solid Tumors or Lymphomas

A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas

A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer

Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma

Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma Patients

A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer

Ph II Study of Perifosine Plus Gleevec for Patients With GIST

Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients